AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimikare-MSR 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Nitro Cadineur

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimikare-MSR 2mg/500mg Tablet

Diabeglim-2/500, a dual-action antidiabetic medication, combines two agents to manage type 2 diabetes in adults. It effectively regulates blood glucose. Administer Diabeglim-2/500 with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continuous use is crucial; abrupt cessation, without medical guidance, can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect; be aware of symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Maintain regular meals and carry a rapid-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabeglim-2/500 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment; pregnancy or breastfeeding necessitates medical consultation. Regular blood glucose monitoring is essential; your doctor may also order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimikare-MSR 2mg/500mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimikare-MSR 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimikare-MSR 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimikare-MSR 2mg/500mg tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Glimikare-MSR 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimikare-MSR 2mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Glimikare-MSR 2mg/500mg tablets with a meal.

How Glimikare-MSR 2mg/500mg Tablet works:

Glimepiride/Metformin 2mg/500mg tablets (Glimikare-MSR) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Glimikare-MSR 2mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimikare-MSR 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimikare-MSR 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by abnormally low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with impaired kidney function, Glimikare-MSR 2mg/500mg tablets require careful administration and may necessitate dosage modification. Patients with severely compromised kidney function should avoid this medication. Close monitoring of kidney function is recommended throughout the treatment period. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Glimikare-MSR 2mg/500mg tablets cautiously. Dosage modification may be necessary for these patients. Medical advice is recommended. Individuals with mild to moderate hepatic dysfunction typically begin treatment with a reduced Glimikare-MSR 2mg/500mg tablet dose; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimikare-MSR 2mg/500mg Tablet :

Should you forget a Glimikare-MSR 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimikare-MSR 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimikare-MSR 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimikare-MSR 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimikare-MSR 2mg/500mg Tablets and seek immediate medical attention.
Glimikare-MSR 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimikare-MSR 2mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimikare-MSR 2mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glimikare-MSR 2mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimikare-MSR 2mg/500mg tablets with alcohol is unsafe. Alcohol can exacerbate the medication's effects, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glimikare-MSR 2mg/500mg T...
47
MRP 57
17% off